Literature DB >> 19176230

Walleye dermal sarcoma virus rv-cyclin inhibits NF-kappaB-dependent transcription.

Sandra L Quackenbush1, Ashley Linton, Connie D Brewster, Joel Rovnak.   

Abstract

The retroviral cyclin protein (rv-cyclin) of walleye dermal sarcoma virus contains two known functional domains, a cyclin box motif and a carboxy terminal transcription activation domain (AD). The AD contacts TATA-binding protein-associated factor 9 (TAF9), and this action is necessary for both positive and negative regulation of transcription from host and viral promoters. Negative regulation occurs via interference with TAF9 binding by transcriptional activators. Transcription factors that share a functional TAF9-binding motif include NF-kappaB. Rv-cyclin down regulates NF-kappaB-dependent transcription, whether induced by TNFalpha or by direct phosphorylation of IkappaB by expressed MEKK1. In rv-cyclin-expressing cells, NF-kappaB p65 is phosphorylated and translocated to the nucleus, where it forms heterodimers with p50 and binds NF-kappaB response elements. Furthermore, interference with NF-kappaB is dependent upon an intact TAF9-binding motif in rv-cyclin. The outcome of this NF-kappaB down regulation is likely to be important in the control of virus replication and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176230      PMCID: PMC2694946          DOI: 10.1016/j.virol.2008.12.026

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  31 in total

1.  Divergent hTAFII31-binding motifs hidden in activation domains.

Authors:  Y Choi; S Asada; M Uesugi
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

2.  The alpha-helical FXXPhiPhi motif in p53: TAF interaction and discrimination by MDM2.

Authors:  M Uesugi; G L Verdine
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 3.  The innate immune response of finfish--a review of current knowledge.

Authors:  Shona K Whyte
Journal:  Fish Shellfish Immunol       Date:  2007-06-22       Impact factor: 4.581

Review 4.  Shared principles in NF-kappaB signaling.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

5.  Intracellular targeting of walleye dermal sarcoma virus Orf A (rv-cyclin).

Authors:  J Rovnak; J W Casey; S L Quackenbush
Journal:  Virology       Date:  2001-02-01       Impact factor: 3.616

6.  Inhibition of nuclear factor-kappaB-mediated transcription by association with the amino-terminal enhancer of split, a Groucho-related protein lacking WD40 repeats.

Authors:  T Tetsuka; H Uranishi; H Imai; T Ono; S Sonta; N Takahashi; K Asamitsu; T Okamoto
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

7.  Tumorigenic adenovirus type 12 E1A inhibits phosphorylation of NF-kappaB by PKAc, causing loss of DNA binding and transactivation.

Authors:  Hancheng Guan; Junfang Jiao; Robert P Ricciardi
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

8.  Walleye dermal sarcoma virus cyclin interacts with components of the mediator complex and the RNA polymerase II holoenzyme.

Authors:  Joel Rovnak; Sandra L Quackenbush
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Establishment of productively infected walleye dermal sarcoma explant cells.

Authors:  Joel Rovnak; Rufina N Casey; Connie D Brewster; James W Casey; Sandra L Quackenbush
Journal:  J Gen Virol       Date:  2007-09       Impact factor: 3.891

10.  A238L inhibits NF-ATc2, NF-kappa B, and c-Jun activation through a novel mechanism involving protein kinase C-theta-mediated up-regulation of the amino-terminal transactivation domain of p300.

Authors:  Aitor G Granja; Neil D Perkins; Yolanda Revilla
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

View more
  7 in total

1.  Transgenic expression of walleye dermal sarcoma virus rv-cyclin (orfA) in zebrafish does not result in tissue proliferation.

Authors:  Thomas A Paul; Joel Rovnak; Sandra L Quackenbush; Kathleen Whitlock; Huiqing Zhan; Zhiyuan Gong; Jan Spitsbergen; Paul R Bowser; James W Casey
Journal:  Mar Biotechnol (NY)       Date:  2010-03-28       Impact factor: 3.619

2.  Retroviral cyclin enhances cyclin-dependent kinase-8 activity.

Authors:  Joel Rovnak; Connie D Brewster; Sandra L Quackenbush
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Retroviral cyclin controls cyclin-dependent kinase 8-mediated transcription elongation and reinitiation.

Authors:  Claire H Birkenheuer; Connie D Brewster; Sandra L Quackenbush; Joel Rovnak
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  The retroviral cyclin of walleye dermal sarcoma virus binds cyclin-dependent kinases 3 and 8.

Authors:  Connie D Brewster; Claire H Birkenheuer; Megan B Vogt; Sandra L Quackenbush; Joel Rovnak
Journal:  Virology       Date:  2010-11-09       Impact factor: 3.616

5.  Walleye dermal sarcoma virus: expression of a full-length clone or the rv-cyclin (orf a) gene is cytopathic to the host and human tumor cells.

Authors:  Kun Xu; Ting Ting Zhang; Ling Wang; Cun Fang Zhang; Long Zhang; Li Xia Ma; Ying Xin; Chong Hua Ren; Zhi Qiang Zhang; Qiang Yan; Daniel Martineau; Zhi Ying Zhang
Journal:  Mol Biol Rep       Date:  2012-10-26       Impact factor: 2.316

6.  Walleye dermal sarcoma virus: molecular biology and oncogenesis.

Authors:  Joel Rovnak; Sandra L Quackenbush
Journal:  Viruses       Date:  2010-09-22       Impact factor: 5.818

7.  Vaccinia virus inhibits NF-κB-dependent gene expression downstream of p65 translocation.

Authors:  Rebecca P Sumner; Carlos Maluquer de Motes; David L Veyer; Geoffrey L Smith
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.